Morgan Lab Publications

Learn more about research being performed in the Morgan Lab by reviewing the latest publications below.

Selected Publications

Differential RNA splicing as a potentially important driver mechanism in multiple myeloma

Bauer, Michael A; Ashby, Cody; Wardell, Christopher; Boyle, Eileen M; Ortiz, Maria; Flynt, Erin; Thakurta, Anjan; Morgan, Gareth; Walker, Brian A

Haematologica (Roma). 2020 Feb 20;

Antibody-based targeting of BCMA in multiple myeloma

Morgan, Gareth J; Williams, Louis

Lancet oncology. 2020 Feb ; 21:186-187

BRAF and DIS3 Mutations Associate with Adverse Outcome in a Long-term Follow-up of Patients with Multiple Myeloma

Boyle, Eileen M; Ashby, Cody; Tytarenko, Ruslana; Deshpande, Shayu; Wang, Yan; Sawyer, Jeffrey; Tian, Erming; Johnson, Sarah; Rutherford, Michael W; Wardell, Christopher P; Bauer, Michael A; Thanendrarajan, Sharmilan; Schinke, Carolina; Zangari, Maurizio; van Rhee, Frits; Wang, Hongwei; Rosenthal, Adam; Hoering, Antje; Flynt, Erin; Thakurta, Anjan; Dumontet, Charles; Facon, Thierry; Cairns, David A; Jackson, Graham H; Barlogie, Bart; Davies, Faith E; Morgan, Gareth J; Walker, Brian A

Clinical cancer research. 2020 Jan 27;

Long-term outcomes after autologous stem cell transplantation for multiple myeloma

Nishimura, Katherine K; Barlogie, Bart; van Rhee, Frits; Zangari, Maurizio; Walker, Brian A; Rosenthal, Adam; Schinke, Carolina; Thanendrarajan, Sharmilan; Davies, Faith E; Hoering, Antje; Morgan, Gareth J

Blood advances. 2020 Jan 28; 4:422-431

Reconstructing the evolutionary history of multiple myeloma

Maura, F; Rustad, E H; Boyle, E M; Morgan, G J

Bailliere's best practice & research. Clincial haematology. 2020;

Role of AID in the temporal pattern of acquisition of driver mutations in multiple myeloma [Letter]

Maura, Francesco; Rustad, Even H; Yellapantula, Venkata; Åuksza, Marta; Hoyos, David; Maclachlan, Kylee H; Diamond, Benjamin T; Greenbaum, Benjamin D; Morgan, Gareth; Lesokhin, Alexander; Papaemmanuil, Elli; Landgren, Ola

Leukemia. 2019 Dec 13;

Response-adapted intensification with cyclophosphamide, bortezomib, and dexamethasone versus no intensification in patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial

Jackson, Graham H; Davies, Faith E; Pawlyn, Charlotte; Cairns, David A; Striha, Alina; Collett, Corinne; Waterhouse, Anna; Jones, John R; Kishore, Bhuvan; Garg, Mamta; Williams, Cathy D; Karunanithi, Kamaraj; Lindsay, Jindriska; Wilson, Jamie N; Jenner, Matthew W; Cook, Gordon; Kaiser, Martin F; Drayson, Mark T; Owen, Roger G; Russell, Nigel H; Gregory, Walter M; Morgan, Gareth J

Lancet. Haematology. 2019 Dec ; 6:e616-e629

The relative importance of factors predicting outcome for myeloma patients at different ages: results from 3894 patients in the Myeloma XI trial

Pawlyn, Charlotte; Cairns, David; Kaiser, Martin; Striha, Alina; Jones, John; Shah, Vallari; Jenner, Matthew; Drayson, Mark; Owen, Roger; Gregory, Walter; Cook, Gordon; Morgan, Gareth; Jackson, Graham; Davies, Faith

Leukemia. 2020 Feb ; 34:604-612

See All Publications

Morgan Lab Publications | NYU Langone Health